Work

The Role of Hospital Pharmacists and Pharmaceutical-Care Interventions in the Personalized Management of Patients with Non-Small-Cell Lung Cancer: A Scoping Review

Year: 2026
Type: article
Study design: Systematic Review
Abstract: Background: Patients with non-small-cell lung cancer (NSCLC) increasingly receive oral targeted therapies and immune checkpoint inhibitors, creating complex medication-management and toxicity-monitoring needs. Pharmacists may contribute through medication optimization, adherence support, patient education, drug-interaction management and multidisciplinary toxicity prevention. Objectives: The objectives of this study were To systematically map the published evidence describing pharmacist and pharmaceutical-care roles relevant to medication safety, adherence, toxicity management, and treatment continuity in NSCLC. Methods: A scoping review was conducted using PubMed/MEDLINE and Web of Science, supplemented by citation and supplementary searching. The search was limited to English-language publications published between 28 August 2016 and 28 August 2026. After reconciliation, 481 unique records were screened. Eligibility was assessed against a NSCLC-specific population and pharmacy/pharmaceutical-care concept criteria. Evidence was classified as core/direct or contextual/supporting. The selection process was reported according to PRISMA-ScR. Results: Of 481 unique records screened, 444 were excluded at title/abstract screening and 37 reports underwent an eligibility assessment. Twenty-three were excluded at this stage, leaving 14 sources of evidence: 11 core/direct and three contextual/supporting sources. Core evidence covered medication optimization and drug–drug interactions, adherence monitoring, adverse-event/toxicity management, patient education, and pharmacist-led ambulatory or multidisciplinary services. Conclusions: Pharmacists contribute meaningfully to medication safety, adherence, toxicity management, and treatment continuity in NSCLC, but the evidence base remains heterogeneous. Larger prospective studies and economic evaluations are needed.
Source: Pharmacy
Language: English
Subfield: Pharmacy
Open Access status: gold
Estimated APC paid: $2,172
OpenAlex ID: W7223569011
FWCI:
Cites: 26
Cited by:
Related to: 10